Comparison of Two Formulations of Proellex for Oral Administration
NCT02141061
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Telapristone Acetate, Proellex 12 mg Formulation A
DRUG:
Telapristone Acetate, Proellex 12 mg Formulation B
Sponsor
Repros Therapeutics Inc.